Skip to content

SCREENER CHART SD50 CALENDAR NEWS

...

ADC Therapeutics S.A. (ADCT) Stock · BUY · RECOVERY | LOPJLB

ADC Therapeutics S.A. (ADCT)

Healthcare · Biotechnology · NYSE · CH

$1.73+8.81%Close

BUYRECOVERY · day 4

ADCT▲ BUY

$1.73+8.81%

Overview FinancialsFin EarningsEarn Analyst & RatingsAnalyst News Holders & ETFsHold Options

Key stats

Short interest · FINRA settlement 2026-09-30

Market cap: $220M
Beta: 1.86
P/E (TTM): -1.92

Short % float: 7.09%
Days to cover: 4.4
SI change: +27.9%

1W: +53.10%
1M: +55.86%

vs SPY 1W: +51.94%
vs SPY 1M: +52.86%

Industry peers

FMP comparable companies · ranked by market cap

RAPTRAPT Therapeutics, Inc.$1.6B$58.01
OMERBUYOmeros Corporation$1.4BRECOVERYQ 18$19.12+3.71%
ALMSSELLAlumis Inc.$860MCRISISQ 2$6.97+2.73%
LXRXSELLLexicon Pharmaceuticals, Inc.$782MCRISISQ 5$1.76-4.55%
FDMTSELL4D Molecular Therapeutics, Inc.$664MCRISISQ 4$12.70+4.96%

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Company

ADC Therapeutics S.A. operates as a commercial-stage biotechnology company, focused on developing antibody-drug conjugates (ADCs) for the treatment of hematological malignancies and solid tumors. Its flagship product, ZYNLONTA, is presently being evaluated in multiple clinical…

Employees: 191
Headquarters: CH
Founded: 2020
Exchange: NYSE
Sector: Healthcare
Industry: Biotechnology
Shares out: 127.2M
Float: 76.5%

adctherapeutics.com ↗

Key executives

Ameet Mallik — Chief Executive Officer & Director

Mohamed Zaki — Chief Medical Officer

Jose I. Carmona — Chief Financial Officer

SEC filings

EDGAR · CIK 17719100 · ADCT

All filings
10-K
10-Q
8-K
Form 4

Analyst consensus

Hold

Bullish541.7%

Neutral650.0%

Bearish18.3%

L $2.00Avg $3.50H $5.00

Target$3.50+102.31%

Last$1.73

Company news

prnewswire.com · 2d ago

ADC Therapeutics Announces Comprehensive Strategic Financial Restructuring Marking Key Capital Structure Improvements

marketwatch.com · 19d ago

These beaten-down stocks could bounce back in January, if history is any guide

prnewswire.com · 37d ago

ADC Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference

marketbeat.com · 58d ago

ADC Therapeutics Q2 Earnings Call Highlights

seekingalpha.com · 58d ago

ADC Therapeutics SA (ADCT) Q2 2026 Earnings Call Transcript

zacks.com · 58d ago

ADC Therapeutics SA (ADCT) Reports Q2 Loss, Lags Revenue Estimates

prnewswire.com · 58d ago

ADC Therapeutics Reports Second Quarter 2026 Financial Results and Provides Operational Updates

prnewswire.com · 65d ago

ADC Therapeutics to Host Second Quarter 2026 Financial Results Conference Call on August 13, 2026

Market news & ticker search · RSS for ADCT

LOPJLB

Independent quant research on U.S. equities & ETFs. Not personalized advice.

Product

Screener Chart Compare SD50 Thesis News Calendar

Desk

Market Heatmap Market Hours FOMC Desk Treasury Rates Congress Trades Prediction Markets

Research

How It Works Methodology Track Record Editorial Blog Changelog

Ledgers

Bull Spreads Cash-Secured Puts Covered Calls Long Puts Long Calls

Screeners

CEF Screener REIT Screener BDC Screener Preferred Screener Dividend Screener ETF Screener Crypto Screener S&P 500 Screener

Company

Pricing About Contact

Agents

GitHub·Research Chat·MCPENT·Developers

© 2026 LOPJLB Research. All rights reserved.

@lopjlb contact@lopjlb.com

RANGE

LOPJLB.COM

OHLC🔒EMALEVELS🔒STOP🔒FLIP🔒52WSIGNALS🔒BUY🔒SELL🔒EXH🔒EXH ZONE